| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 28, 2025 | SUPN Supernus Pharmaceuticals, Inc. | Bhatt Padmanabh P.69 | Sr. VP Of Ip, CSO | Sell | 3,273 | $39.62 | $129,676.26 | -13.9% | -17.6% | +25.0% | |
| Jan 27, 2025 | UTHR United Therapeutics Corp | Benkowitz Michael47 | President And COO | Sell | 10,000 | $370.71 | $3,707,080.71 | -49.0% | -19.6% | +29.0% | |
| Jan 27, 2025 | NBIX Neurocrine Biosciences Inc | Gorman Kevin Charles56 | Director | Sell | 146,105 | $149.46 | $21,836,502.65 | -22.1% | -28.2% | -9.6% | |
| Jan 27, 2025 | LQDA Liquidia Corp | Adair Jason | Chief Business Officer | Sell | 445 | $14.20 | $6,319.00 | -0.2% | +1.6% | +203.2% | |
| Jan 24, 2025 | ETST Earth Science Tech, Inc. | Tabraue Mario Guillermo | COO | Buy | 20,000 | $0.23 | $4,600.00 | +0.2% | - | - | |
| Jan 24, 2025 | HIMS Hims & Hers Health, Inc. | Chi Michael | Chief Commercial Officer | Sell | 17,304 | $31.00 | $536,424.00 | -8.2% | -8.8% | -4.0% | |
| Jan 23, 2025 | HIMS Hims & Hers Health, Inc. | Dudum Andrew47 | Chief Executive Officer | Sell | 27,098 | $30.08 | $815,029.26 | -49.3% | -13.5% | -4.1% | |
| Jan 23, 2025 | BSPK Bespoke Extracts, Inc. | Feinsod Michael | CEO | Buy | 8,000 | $0.11 | $845.00 | +0.2% | - | - | |
| Jan 22, 2025 | HROW Harrow, Inc. | Opaleye Management Inc.60 | 10% Owner | Sell | 20,000 | $35.59 | $711,814.00 | -11.4% | -33.7% | +31.2% | |
| Jan 22, 2025 | HIMS Hims & Hers Health, Inc. | Dudum Andrew47 | Chief Executive Officer | Sell | 14,569 | $30.08 | $438,184.41 | -20.7% | -14.7% | +2.7% | |
| Jan 21, 2025 | LQDA Liquidia Corp | Saggar Rajeev | Chief Medical Officer | Sell | 2,445 | $13.00 | $31,785.00 | -0.9% | -2.4% | +193.6% | |
| Jan 21, 2025 | AVDL Avadel Pharmaceuticals Plc | Palczuk Linda78 | Director | Buy | 5,000 | $7.93 | $39,640.00 | +7.9% | +0.8% | +172.3% | |
| Jan 21, 2025 | UTHR United Therapeutics Corp | Benkowitz Michael47 | President And COO | Sell | 10,000 | $364.91 | $3,649,112.02 | -33.4% | -22.8% | +27.7% | |
| Jan 21, 2025 | HIMS Hims & Hers Health, Inc. | Baird Melissa | Chief Operating Officer | Sell | 67,687 | $29.35 | $1,986,730.71 | -1.5% | -13.3% | -3.1% | |
| Jan 21, 2025 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 54,153 | $29.90 | $1,619,108.04 | -13.9% | -13.3% | -3.1% | |
| Jan 21, 2025 | HIMS Hims & Hers Health, Inc. | Chi Michael | Chief Commercial Officer | Sell | 306 | $28.68 | $8,776.08 | -0.2% | -13.3% | -3.1% | |
| Jan 17, 2025 | ESPR Esperion Therapeutics, Inc. | Halladay Benjamin | Chief Financial Officer | Sell | 9 | $2.27 | $20.39 | - | -57.0% | +37.6% | |
| Jan 17, 2025 | ESPR Esperion Therapeutics, Inc. | Warren Eric60 | Chief Commercial Officer | Sell | 123 | $2.26 | $277.98 | - | -57.0% | +37.6% | |
| Jan 16, 2025 | HIMS Hims & Hers Health, Inc. | Dudum Andrew47 | Chief Executive Officer | Sell | 83,994 | $27.04 | $2,271,413.73 | -7.2% | -3.5% | +12.3% | |
| Jan 16, 2025 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 787,500 | $0.20 | $155,757.20 | - | - | - | |
| Jan 15, 2025 | LNTH Lantheus Holdings, Inc. | Thrall James H | Director | Sell | 1,000 | $94.76 | $94,760.00 | -2.9% | +10.0% | -30.0% | |
| Jan 15, 2025 | NBIX Neurocrine Biosciences Inc | Gano Kyle54 | Chief Executive Officer | Sell | 65,000 | $141.50 | $9,197,549.84 | -19.4% | -32.5% | -6.5% | |
| Jan 14, 2025 | LQDA Liquidia Corp | Jeffs Roger66 | Chief Executive Officer | Sell | 22,343 | $11.78 | $263,200.54 | -2.1% | +21.7% | +252.0% | |
| Jan 14, 2025 | LQDA Liquidia Corp | Saggar Rajeev | Chief Medical Officer | Sell | 6,249 | $11.78 | $73,613.22 | -2.3% | +21.7% | +252.0% | |
| Jan 14, 2025 | LQDA Liquidia Corp | Kaseta Michael57 | CFO And COO | Sell | 23,370 | $11.78 | $275,298.60 | -5.5% | +21.7% | +252.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.